INTS Principal Accounting Officer John Wesolowski Receives Award

What Happened

• John M. Wesolowski, Principal Accounting Officer at Intensity Therapeutics (INTS), received an award of 11,000 derivative shares/options on July 16, 2026. The grant is reported at $0.00 per share (no cash paid at grant) and is classified as an award/other acquisition (code A).

Key Details

• Transaction date: 2026-07-16; Filing date: 2026-07-20 (filing appears timely).
• Grant: 11,000 derivative shares/options at $0.00 (no immediate cash value reported).
• Shares owned after transaction: not specified in the Form 4.
• Footnote: The award vests in four equal annual installments beginning July 16, 2027, subject to continued service.
• Transaction type: grant/award (derivative), not an exercise or sale.

Context

• This was a compensation grant, not an open-market purchase or sale. Such awards are common for executive pay and do not by themselves signal an immediate buy or sell of company stock. Investors may watch for future vesting, exercises, or any subsequent sales for clearer insider sentiment.